-
Post-Surgical Opioid Prescriptions Safely Cut
A cancer center reduced its opioid pain prescriptions for surgery for a year, without patients reporting more pain, complications, or requests for more pills.
-
How A Brand Climbs To Top Of The Market
It’s all about creating an identity that resonates with consumers.
-
Report – 289 Cell and Gene Therapies in Development
A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration.
-
Self-Powered Sun Exposure Chip, App Developed
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app.
-
Ways to Achieve Financial Harmony
Achieving financial harmony is simply a matter of assertiveness, diligence, consistency and patience.
-
Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study
A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease.
-
Immune Cell Chips to Launch into Space for Microgravity Tests
Chip devices with human immune system and stem cells are among the cargo set for launch today to the International Space Station.
-
Reducing Waste in Your Automated Business
Whether it is the cutting system that needs improving or you would like to tackle idle times, you can review your workflow to make adjustments and improve your efficiency.
-
FDA Identifies Database to Evaluate Precision Diagnostics
The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine.
-
Trial Results Show Gene Transfers Reverse Sickle Cell Disease
Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year.